VIR

9.52

3.82% 0.35

Handel nachbörslich: 9.54 0.02 +0.21%

Vir Biotechnology Inc (VIR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt VIR? Forum Prognose

Schlusskurs vom Vortag:

$9.17

Offen:

$9.47

24-Stunden-Volumen:

2.51M

Relative Volume:

0.77

Marktkapitalisierung:

$1.52B

Einnahmen:

$68.56M

Nettoeinkommen (Verlust:

$-437.99M

KGV:

-3.0089

EPS:

-3.1639

Netto-Cashflow:

$-396.61M

1W Leistung:

+5.54%

1M Leistung:

-0.31%

6M Leistung:

+57.36%

1J Leistung:

+83.43%

1-Tages-Spanne:

$9.20

$9.705

1-Wochen-Bereich:

$8.6501

$9.705

52-Wochen-Spanne:

$4.155

$10.94

Vir Biotechnology Inc Stock (VIR) Company Profile

Firmenname

Vir Biotechnology Inc

Sektor

Healthcare (1111)

Branche

Biotechnology (624)

Telefon

415-906-4324

Adresse

1800 OWENS STREET, SAN FRANCISCO, CA

Mitarbeiter

367

Twitter

@Vir_Biotech

Nächster Verdiensttermin

2024-10-31

Neueste SEC-Einreichungen

VIR's Discussions on Twitter

Compare VIR vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VIR Vir Biotechnology Inc	9.52	1.47B	68.56M	-437.99M	-396.61M	-3.1639
VRTX Vertex Pharmaceuticals Inc	443.92	109.85B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	775.53	80.38B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	785.07	47.60B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	327.25	42.63B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	312.19	33.72B	5.36B	287.73M	924.18M	2.5229

Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-24	Hochstufung	Raymond James	Outperform → Strong Buy
2025-09-03	Eingeleitet	Evercore ISI	Outperform
2025-08-27	Hochstufung	BofA Securities	Neutral → Buy
2024-01-29	Herabstufung	JP Morgan	Overweight → Neutral
2023-09-08	Herabstufung	BofA Securities	Buy → Neutral
2023-03-06	Hochstufung	JP Morgan	Neutral → Overweight
2023-02-21	Hochstufung	Goldman	Neutral → Buy
2023-01-27	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2022-09-14	Eingeleitet	SVB Leerink	Outperform
2022-09-09	Eingeleitet	Morgan Stanley	Underweight
2022-03-03	Hochstufung	Robert W. Baird	Underperform → Neutral
2021-12-21	Herabstufung	Robert W. Baird	Neutral → Underperform
2021-10-25	Hochstufung	JP Morgan	Underweight → Neutral
2021-09-22	Herabstufung	Goldman	Buy → Neutral
2021-06-04	Fortgesetzt	Robert W. Baird	Neutral
2021-01-27	Herabstufung	JP Morgan	Neutral → Underweight
2021-01-20	Bestätigt	H.C. Wainwright	Buy
2020-10-05	Eingeleitet	BofA Securities	Buy
2020-09-14	Hochstufung	Goldman	Neutral → Buy
2020-09-11	Hochstufung	JP Morgan	Underweight → Neutral
2020-08-20	Eingeleitet	Needham	Buy
2020-03-19	Herabstufung	JP Morgan	Neutral → Underweight
2020-03-13	Herabstufung	Goldman	Buy → Neutral
2020-02-27	Herabstufung	Robert W. Baird	Neutral → Underperform
2020-02-04	Herabstufung	JP Morgan	Overweight → Neutral
2019-11-14	Eingeleitet	Robert W. Baird	Neutral
2019-11-05	Eingeleitet	Barclays	Overweight
2019-11-05	Eingeleitet	Cowen	Outperform
2019-11-05	Eingeleitet	Goldman	Buy
2019-11-05	Eingeleitet	JP Morgan	Overweight

Alle ansehen

Vir Biotechnology Inc Aktie (VIR) Neueste Nachrichten

04:26 AM

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

04:26 AM

Apr 07, 2026

Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares - MarketBeat

Apr 07, 2026

Vir Biotechnology (VIR) CEO auto-sells 72,559 shares to cover RSU tax - Stock Titan

Apr 07, 2026

VIR Biotechnology Inc (NASDAQ:VIR) Emerges as a High-Growth Momentum Pick - ChartMill

Apr 07, 2026

VIR SEC FilingsVir Biotechnology, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 07, 2026

Apr 06, 2026

Exit Recap: What is the Moat Score of Vir Biotechnology Inc2026 Bull vs Bear & Weekly Momentum Stock Picks - baoquankhu1.vn

Apr 06, 2026

VIR (NASDAQ: VIR) Form 144 shows 72,559-share sale after vesting - Stock Titan

Apr 06, 2026

Evercore ISI Group Initiates Coverage of Vir Biotechnology (VIR) with Outperform Recommendation - MSN

Apr 06, 2026

Apr 04, 2026

VIR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026

Apr 02, 2026

Market Catalysts: Is Vir Biotechnology Inc a good stock for dollar cost averaging2026 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn

Apr 02, 2026

Insider Sell: Vicki Sato Sells 22,000 Shares of Vir Biotechnology Inc (VIR) - GuruFocus

Apr 02, 2026

Vir Biotechnology (NASDAQ:VIR) Director Sells $199,540.00 in Stock - MarketBeat

Apr 02, 2026

Vir Biotechnology director Sato sells $199k in shares By Investing.com - za.investing.com

Apr 02, 2026

Vir Biotechnology director Sato sells $199k in shares - Investing.com

Apr 02, 2026

Vir Biotechnology (VIR) director sells 22,000 shares in open market - Stock Titan

Apr 02, 2026

VIR Earnings History & Surprises | EPS & Revenue Results | VIR BIOTECHNOLOGY INC (NASDAQ:VIR) - ChartMill

Apr 02, 2026

Apr 01, 2026

Vir Biotechnology (VIR) price target increased by 26.10% to 20.74 - MSN

Apr 01, 2026

Mar 30, 2026

Energy Moves: Is Vir Biotechnology Inc stock a smart retirement pickPortfolio Update Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Mar 30, 2026

Bull Bear: Is Vir Biotechnology Inc stock heavily shortedNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn

Mar 30, 2026

Investor Mood: How volatile is LGLWS stockWeekly Earnings Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Why did Vir Biotechnology stock surge 60% after-hours today? - MSN

Mar 29, 2026

Mar 28, 2026